{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:23:13Z","timestamp":1792185793510,"version":"4.4.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001502 82001623 81771533 JYLJ202118"],"award-info":[{"award-number":["82001502 82001623 81771533 JYLJ202118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["19411961100"],"award-info":[{"award-number":["19411961100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Progestin is an alternative to gonadotropin-releasing hormone (GnRH) analogues in the follicular phase to suppress the premature luteinizing hormone (LH) surge in women with polycystic ovary syndrome (PCOS). However, progestin-primed ovarian stimulation (PPOS) is always accompanied by increased pituitary suppression and gonadotropin consumption. Previous studies suggested that letrozole appeared to have the potential to reduce the total gonadotropin dose required for ovarian stimulation. A retrospective cohort study was performed to evaluate the efficacy of PPOS with or without letrozole in infertile women with PCOS.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This retrospective cohort study included 448 women with PCOS who underwent controlled ovarian stimulation (COS) with human menopausal gonadotropin (hMG) and medroxyprogesterone acetate (MPA) (n = 224) or hMG and MPA cotreatment with LE (n = 224) from January 2018 to March 2021 after propensity-score matching. The primary outcome measure was the hMG dose. The secondary outcomes were the durations of ovarian stimulation, the implantation rate, the number of oocytes retrieved and viable embryos, oocyte maturity and fertilization rates, the percentage of women with profound pituitary suppression (luteinizing hormone [LH] &amp;lt;1.0 IU\/L on the trigger day).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The hMG doses (1949.89 \u00b1 725.03 IU vs 2017.41 \u00b1 653.32 IU<jats:bold>,<\/jats:bold><jats:italic>p<\/jats:italic> &amp;gt; 0.05) and durations of ovarian stimulation (9.03 \u00b1 1.79 days vs 9.21 \u00b1 2.18 days<jats:bold>,<\/jats:bold><jats:italic>p<\/jats:italic> &amp;gt; 0.05) were similar between the two groups. The implantation rate was significantly higher in the study group (MPA + hMG + LE) than in the control group (MPA + hMG) (42.22 vs 34.69%, <jats:italic>p<\/jats:italic> &amp;lt; 0.05). The numbers of oocytes and embryos retrieved were similar between the two groups. Interestingly, letrozole cotreatment was associated with decreased oocyte maturity and fertilization rates in comparison with standard PPOS protocols even though mature and fertilized oocyte yields were comparable. Compared with those in the control group, the LH values on the trigger day were significantly higher in the study group, together with significantly reduced pituitary suppression.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Letrozole combined with PPOS cannot reduce hMG consumption in PCOS patients undergoing IVF treatment and shows no beneficial effect on cycle characteristics of COS. However, letrozole supplementation manifests as a superior implantation rate to that of the standard PPOS protocol in women with PCOS.<\/jats:p>","DOI":"10.3389\/fphys.2022.965210","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T05:10:23Z","timestamp":1660885823000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Yali","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"B2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.rbmo.2021.12.006","article-title":"Co-Treatment with letrozole during ovarian stimulation for IVF\/ICSI: A systematic review and meta-analysis","volume":"44","author":"Bulow","year":"2022","journal-title":"Reprod. Biomed. Online"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.fertnstert.2006.11.034","article-title":"Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells","volume":"87","author":"Cai","year":"2007","journal-title":"Fertil. Steril."},{"key":"B4","doi-asserted-by":"publisher","first-page":"744968","DOI":"10.3389\/fphys.2021.744968","article-title":"Luteinizing hormone suppression by progestin-primed ovarian stimulation is associated with higher implantation rate for patients with polycystic ovary syndrome who underwent in vitro fertilization\/intracytoplasmic sperm injection cycles: Comparing with short protocol","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF01133388","article-title":"A formula for scoring human embryo growth rates in in vitro fertilization: Its value in predicting pregnancy and in comparison with visual estimates of embryo quality","volume":"3","author":"Cummins","year":"1986","journal-title":"J. Vitro Fert. Embryo Transf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0093-691x(82)90100-5","article-title":"Effect of gonadotropins, steroids and culture media on bovine oocyte maturation in vitro","volume":"18","author":"Fukui","year":"1982","journal-title":"Theriogenology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.fertnstert.2012.09.042","article-title":"The use of aromatase inhibitors in in vitro fertilization","volume":"98","author":"Garcia-Velasco","year":"2012","journal-title":"Fertil. Steril."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/oxfordjournals.humrep.a136312","article-title":"Embryo score to predict implantation after in-vitro fertilization: Based on 957 single embryo transfers","volume":"10","author":"Giorgetti","year":"1995","journal-title":"Hum. Reprod."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/humrep\/dev155","article-title":"Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients","volume":"30","author":"Goldrat","year":"2015","journal-title":"Hum. Reprod."},{"key":"B11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1530\/REP-19-0342","article-title":"Necessity for LH in selection and continued growth of the bovine dominant follicle","volume":"159","author":"Gomez-Leon","year":"2020","journal-title":"Reproduction"},{"key":"B12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/humrep\/deh682","article-title":"Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study","volume":"20","author":"Hugues","year":"2005","journal-title":"Hum. Reprod."},{"key":"B13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/humrep\/deh601","article-title":"Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF\/ICSI patients: Optimal changes in LH and progesterone for clinical pregnancy","volume":"20","author":"Huirne","year":"2005","journal-title":"Hum. Reprod."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.12669\/pjms.321.8329","article-title":"Fertilization rate and its determinants in intracytoplasmic sperm injection","volume":"32","author":"Jawed","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/jcpt.13567","article-title":"Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: A retrospective cohort study","volume":"47","author":"Jiang","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil. Steril."},{"key":"B17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil. Steril."},{"key":"B18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/cen.13532","article-title":"Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization\/intracytoplasmic sperm injection: A prospective randomized controlled trial","volume":"88","author":"Liu","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.fertnstert.2016.07.1068","article-title":"Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist","volume":"106","author":"Lu","year":"2016","journal-title":"Fertil. Steril."},{"key":"B20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/humupd\/dmw047","article-title":"New stimulation regimens: Endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum. Reprod. Update"},{"key":"B22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1439-0531.2008.01190.x","article-title":"Factors affecting oocyte quality: Who is driving the follicle?","volume":"43","author":"Mermillod","year":"2008","journal-title":"Reprod. Domest. Anim."},{"key":"B23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1242\/dev.56.1.319","article-title":"Effect of follicular steroids on the maturation and fertilization of mammalian oocytes","volume":"56","author":"Moor","year":"1980","journal-title":"Development"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: Impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"B26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/humrep\/dew355","article-title":"Response to ovarian stimulation is not impacted by a breast cancer diagnosis","volume":"32","author":"Quinn","year":"2017","journal-title":"Hum. Reprod."},{"key":"B27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/humupd\/dmn033","article-title":"Use of letrozole in assisted reproduction: A systematic review and meta-analysis","volume":"14","author":"Requena","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"B28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2007.02.011","article-title":"A quantitative assessment of follicle size on oocyte developmental competence","volume":"90","author":"Rosen","year":"2008","journal-title":"Fertil. Steril."},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam","year":"2004","journal-title":"Fertil. Steril."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum. Reprod."},{"key":"B31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"Thessaloniki","year":"2008","journal-title":"Hum. Reprod."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.ajem.2019.05.018","article-title":"Ovarian hyperstimulation syndrome: A review for emergency clinicians","volume":"37","author":"Timmons","year":"2019","journal-title":"Am. J. Emerg. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101643","DOI":"10.1016\/j.jogoh.2019.101643","article-title":"The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study","volume":"49","author":"Tshzmachyan","year":"2020","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: A double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Med. Baltim."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.2527\/1998.76123079x","article-title":"In vitro maturation and fertilization techniques for assessment of semen quality and boar fertility","volume":"76","author":"Xu","year":"1998","journal-title":"J. Anim. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"676133","DOI":"10.3389\/fendo.2021.676133","article-title":"Letrozole for female infertility","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"100494","DOI":"10.1016\/j.lanwpc.2022.100494","article-title":"Changes in the prevalence of polycystic ovary syndrome in China over the past decade","volume":"25","author":"Yang","year":"2022","journal-title":"Lancet Reg. Health. West. pac."},{"key":"B38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12958-019-0483-x","article-title":"Letrozole supplementation during controlled ovarian stimulation in expected high responders: A pilot randomized controlled study","volume":"17","author":"Yang","year":"2019","journal-title":"Reprod. Biol. Endocrinol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.965210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T05:10:27Z","timestamp":1660885827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.965210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":38,"alternative-id":["10.3389\/fphys.2022.965210"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.965210","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"article-number":"965210"}}